The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 533 KB) and Technical Notes (PDF, 752 KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Table 21.16

Cancer of the Ovary (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases, 2007-2011
Females by Race
Histologya All Races White Black Asian/
Pacific Islander
American Indian
/Alaska Nativeb
Hispanicc
Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent
Carcinoma 24,578 91.7% 20,563 92.2% 1,912 88.3% 1,824 90.3% 116 92.8% 2,859 87.3%
Epidermoid carcinomad (8051-8131) 191 0.7% 149 0.7% 18 0.8% 21 1.0% - - 28 0.9%
Adenocarcinomae 22,524 84.0% 18,946 84.9% 1,650 76.2% 1,680 83.1% 105 84.0% 2,560 78.1%
Adenocarcinoma, NOS (8140) 3,291 12.3% 2,679 12.0% 403 18.6% 183 9.1% - - 323 9.9%
Papillary adenocarcinoma, NOS (8050,8260) 404 1.5% 350 1.6% 34 1.6% - - - - 47 1.4%
Clear cell adenocarcinoma (8310,9110) 1,407 5.2% 1,089 4.9% 51 2.4% 257 12.7% - - 146 4.5%
Endometrioid carcinoma (8380-8383,8570) 2,593 9.7% 2,186 9.8% 121 5.6% 245 12.1% - - 353 10.8%
Cystadenocarcinoma, NOS (8440,8450) 110 0.4% 88 0.4% - - - - - - - -
Serous cystadenocarcinoma (8441) 5,601 20.9% 4,798 21.5% 383 17.7% 346 17.1% 35 28.0% 593 18.1%
Papillary serous cystadenocarcinoma (8460-8462) 6,307 23.5% 5,435 24.4% 463 21.4% 357 17.7% 30 24.0% 699 21.3%
Mucinous cystadenocarcinoma (8470-8473) 403 1.5% 332 1.5% 29 1.3% 35 1.7% - - 66 2.0%
Mucinous adenocarcinoma (8480,8482) 949 3.5% 756 3.4% 80 3.7% 101 5.0% - - 137 4.2%
Mucin-producing adenocarcinoma(8481) 48 0.2% 39 0.2% - - - - - - - -
Other adenocarcinomaf 1,411 5.3% 1,194 5.4% 64 3.0% 133 6.6% - - 174 5.3%
Other specific carcinomasg 617 2.3% 448 2.0% 120 5.5% 37 1.8% - - 103 3.1%
Stromal cell tumor (8620-8631,8650) 425 1.6% 294 1.3% 97 4.5% 22 1.1% - - 70 2.1%
Otherh 192 0.7% 154 0.7% 23 1.1% - - - - 33 1.0%
Unspecified, Carcinoma, NOS (8010,8020-8022) 1,246 4.6% 1,020 4.6% 124 5.7% 86 4.3% - - 168 5.1%
Sarcoma and other soft tissue tumors (8680-8713,8800-8921, 8990-8991,9040-9044, 9120-9136,9141-9340, 9540-9582) 96 0.4% 66 0.3% 20 0.9% - - - - 20 0.6%
Other specific types (8240-8246,8720-8790, 8930-8936,8950-8983, 9000-9030,9060-9105, 9350-9364,9380-9513, 9530-9539) 1,852 6.9% 1,452 6.5% 204 9.4% 168 8.3% - - 361 11.0%
Mullerian mixed tumor (8950-8951,8980) 806 3.0% 674 3.0% 73 3.4% 49 2.4% - - 65 2.0%
Teratoma, malignant (9080-9085,9102) 411 1.5% 296 1.3% 54 2.5% 54 2.7% - - 146 4.5%
Other 635 2.4% 482 2.2% 77 3.6% 65 3.2% - - 150 4.6%
Unspecified (8000-8005) 286 1.1% 232 1.0% 29 1.3% 19 0.9% - - 36 1.1%
Totald 26,812 100.0% 22,313 100.0% 2,165 100.0% 2,021 100.0% 125 100.0% 3,276 100.0%

Footnotes:

Source: SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG). Percents may not sum to 100 due to rounding.

a Excludes Kaposi Sarcoma, mesothelioma, lymphomas, leukemias, myelomas, lymphoreticular, and immunoproliferative diseases.

b Estimates for American Indian/Alaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties.

c Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry.

d Epidermoid carcinoma includes squamous, basal, and transitional cell carcinomas.

e Adenocarcinoma includes histologies 8050,8140-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8560,8570-8574,8576,8940-8941,9110.

f Other adenocarcinoma includes histologies 8141-8147,8160-8162,8180-8221,8250-8259,8261-8309,8311-8379,8384-8439,8442-8449, 8451-8459,8463-8469,8474-8479,8483-8507,8514,8520-8551,8560,8571-8574,8576,8940-8941.

g Other specific carcinomas includes histologies 8011-8015,8030-8046,8150-8155,8170-8175,8230-8231,8247-8249,8508,8510-8513, 8561-8562,8575,8580-8671.

h Other subgroup of other specific carcinomas includes histologies 8011-8015,8030-8046,8150-8155,8170-8175,8230-8231,8247-8249,8508,8510-8513,8561-8562,8575,8580-8619,8632-8649,8651-8671.

- Statistic not shown due to fewer than 16 cases during the time period.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.